The Archon Genomics X Prize competition, to be held in September 2013, is intended to spur technology, boost accuracy and drive down costs — currently $3,000–5,000 per genome. Peter Diamandis, the X Prize Foundation’s chief executive, says that the contest will help to establish a standard for a “medical grade” genome, with the high accuracy needed to diagnose or treat a patient.
This time, the X prize Foundation has relaxed the time frame, allowing competitors 30 days — rather than the 10 specified by the 2006 contest — and focused on centenarians, who might carry gene variants promoting longevity. The winning team will be the first to sequence all 100 genomes to 98% completion, with less than one error per million base pairs, and to determine which variants appear on which of the paired chromosomes."
Link to Original Source